Pradeep Bhadauria is the President and Chief Scientific Officer (CSO) at Cipla. He joined the organization in 2020, prior to which he served as CSO and member of the Executive Committee at Amneal Pharmaceutical Inc. Pradeep has also held leadership positions in Apotex, Allergan/Actavis, Watson Pharmaceuticals, Sandoz, and Ranbaxy. With over two decades of experience, Pradeep is an industry veteran with expertise in the area of Pharmaceutical Research and Development.
With a Masters’ degree in Pharmacy from Birla Institute of Technology, Pradeep has a successful track record of developing and filing numerous products, including many first-to-file and first-to-market opportunities. He has worked on multiple dosage forms and has extensive experience in working on complex generics, 505(B)2, specialty, and other difficult-to-formulate products. He also holds several patents and has published research in various publications.
In his current role and a member of the Management Council of Cipla, Pradeep leads Cipla’s Global Integrated Product Development (IPD) organization to strengthen the company’s position as an innovation-led generic and specialty pharmaceutical organization.
Current role